Economic impact in the management of dermatologic toxicities (dTs) induced by the epidermal growth factor receptor inhibitor (EGFRI) cetuximab in colorectal cancer.
2010 ◽
Vol 28
(15_suppl)
◽
pp. 3569-3569
◽
2017 ◽
Vol 57
(4)
◽
pp. 455-473
◽
2009 ◽
Vol 15
(9)
◽
pp. 3184-3188
◽
2012 ◽
Vol 22
(1)
◽
pp. 91-101
◽
2009 ◽
Vol 16
(6)
◽
pp. 554-561
◽
2010 ◽
Vol 101
(2)
◽
pp. 440-447
◽
2009 ◽
Vol 60
(3)
◽
pp. AB55
◽